<DOC>
	<DOC>NCT00957983</DOC>
	<brief_summary>The purpose of this study is to determine whether EP-4 receptor antagonist can prevent the headache expected during a Prostaglandin E2 infusion.</brief_summary>
	<brief_title>EP4-receptor Antagonism and Prostaglandin E2 (PGE2) in a Human Headache Model</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Dinoprostone</mesh_term>
	<criteria>Healthy volunteers Tension headache All other primary forms of headache Cardiovascular, Central Nervous system (CNS) and autoimmune diseases Gastrointestinal disease Previous or clinical signs of mental illness or substance abuse. Participation in a clinical study of a medicinal product without regulatory approval or marketing authorisation within 1 month prior to this trial Pregnancy/nursing Daily intake of medication (except oral contraceptives)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>